254 related articles for article (PubMed ID: 24677340)
41. Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2,3-diones.
Kimble-Hill AC; Parajuli B; Chen CH; Mochly-Rosen D; Hurley TD
J Med Chem; 2014 Feb; 57(3):714-22. PubMed ID: 24444054
[TBL] [Abstract][Full Text] [Related]
42. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
43. Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.
Yan J; De Melo J; Cutz JC; Aziz T; Tang D
Br J Cancer; 2014 May; 110(10):2593-603. PubMed ID: 24762960
[TBL] [Abstract][Full Text] [Related]
44. Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Sreerama L; Sladek NE
Cancer Res; 1994 Apr; 54(8):2176-85. PubMed ID: 8174125
[TBL] [Abstract][Full Text] [Related]
45. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
Sladek NE; Landkamer GJ
Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
[TBL] [Abstract][Full Text] [Related]
46. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
Ma Z; Jiang L; Li B; Liang D; Feng Y; Liu L; Jiang C
Bioorg Med Chem; 2021 Sep; 46():116352. PubMed ID: 34403955
[TBL] [Abstract][Full Text] [Related]
47. Design, Synthesis, Biological Evaluation and In Silico Study of Benzyloxybenzaldehyde Derivatives as Selective ALDH1A3 Inhibitors.
Ibrahim AIM; Ikhmais B; Batlle E; AbuHarb WK; Jha V; Jaradat KT; Jiménez R; Pequerul R; Parés X; Farrés J; Pors K
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641313
[TBL] [Abstract][Full Text] [Related]
48. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice.
Lassen N; Bateman JB; Estey T; Kuszak JR; Nees DW; Piatigorsky J; Duester G; Day BJ; Huang J; Hines LM; Vasiliou V
J Biol Chem; 2007 Aug; 282(35):25668-76. PubMed ID: 17567582
[TBL] [Abstract][Full Text] [Related]
49. Human aldehyde dehydrogenase 3A1 (ALDH3A1) exhibits chaperone-like function.
Voulgaridou GP; Tsochantaridis I; Mantso T; Franco R; Panayiotidis MI; Pappa A
Int J Biochem Cell Biol; 2017 Aug; 89():16-24. PubMed ID: 28526614
[TBL] [Abstract][Full Text] [Related]
50. Dependence of aldehyde dehydrogenase-mediated oxazaphosphorine resistance on soluble thiols: importance of thiol interactions with the secondary metabolite acrolein.
Bunting KD; Townsend AJ
Biochem Pharmacol; 1998 Jul; 56(1):31-9. PubMed ID: 9698086
[TBL] [Abstract][Full Text] [Related]
51. Aldehyde dehydrogenase 3A1 protects airway epithelial cells from cigarette smoke-induced DNA damage and cytotoxicity.
Jang JH; Bruse S; Liu Y; Duffy V; Zhang C; Oyamada N; Randell S; Matsumoto A; Thompson DC; Lin Y; Vasiliou V; Tesfaigzi Y; Nyunoya T
Free Radic Biol Med; 2014 Mar; 68():80-6. PubMed ID: 24316006
[TBL] [Abstract][Full Text] [Related]
52. Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.
Narendra G; Raju B; Verma H; Kumar M; Jain SK; Tung GK; Thakur S; Kaur R; Kaur S; Sapra B; Silakari O
RSC Med Chem; 2024 Jan; 15(1):309-321. PubMed ID: 38283216
[TBL] [Abstract][Full Text] [Related]
53. Investigating the Functional Roles of Aldehyde Dehydrogenase 3A1 in Human Corneal Epithelial Cells.
Voulgaridou GP; Theologidis V; Venetikidou M; Tsochantaridis I; Tsolou A; Koffa M; Panayiotidis MI; Pappa A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982917
[TBL] [Abstract][Full Text] [Related]
54. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
55. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
Sreerama L; Sladek NE
Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195
[TBL] [Abstract][Full Text] [Related]
56. Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes.
Pei Y; Reins RY; McDermott AM
Exp Eye Res; 2006 Nov; 83(5):1063-73. PubMed ID: 16822507
[TBL] [Abstract][Full Text] [Related]
57. Metabolism and transport of oxazaphosphorines and the clinical implications.
Zhang J; Tian Q; Yung Chan S; Chuen Li S; Zhou S; Duan W; Zhu YZ
Drug Metab Rev; 2005; 37(4):611-703. PubMed ID: 16393888
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
Dinavahi SS; Gowda R; Bazewicz CG; Battu MB; Lin JM; Chitren RJ; Pandey MK; Amin S; Robertson GP; Gowda K
Eur J Med Chem; 2020 Feb; 187():111962. PubMed ID: 31887569
[TBL] [Abstract][Full Text] [Related]
59. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress.
Choudhary S; Xiao T; Vergara LA; Srivastava S; Nees D; Piatigorsky J; Ansari NH
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):259-67. PubMed ID: 15623782
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol.
Rekha GK; Sladek NE
Adv Exp Med Biol; 1997; 414():133-46. PubMed ID: 9059615
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
